Patient Guide: A Study to Evaluate the Safety, Tolerability, and Efficacy of Pumitamig Alone or in Combination With Ipilimumab or Cabozantinib in Participants With Advanced Renal Cell Carcinoma (RCC) (ROSETTA RCC-208)

We'll Help You Connect with This Trial

Quri.ai is a free clinical trial matching service. We help patients like you connect directly with research sites conducting this study.

  • Get matched to the right study location for you
  • Connect directly with study coordinators at 69 participating sites
  • Understand eligibility with our simplified screening tool
  • Free service - we're here to help you access clinical research
Trial ID: NCTNCT07293351
Status: NOT_YET_RECRUITING
Condition: Advanced Renal Cell Carcinoma (RCC)
Phase: PHASE1, PHASE2

Find a Study Location Near You

This study is available at 69 research sites. We'll help you connect with the location that's right for you.

Participating sites include:
  • New Haven, Connecticut
  • Washington D.C., District of Columbia
  • Orlando, Florida
  • • And 66 more locations - let us help you find the closest one

Loading interactive enrollment tools...

The full interactive experience will load momentarily